BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.57 USD 2.44% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
BioCryst Pharmaceuticals Inc?
Write Note

Income Statement

Earnings Waterfall
BioCryst Pharmaceuticals Inc

Revenue
412.6m USD
Cost of Revenue
-8m USD
Gross Profit
404.6m USD
Operating Expenses
-445.3m USD
Operating Income
-40.7m USD
Other Expenses
-83.1m USD
Net Income
-123.8m USD

Income Statement
BioCryst Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
19
N/A
14
-27%
17
+25%
41
+143%
49
+19%
48
-2%
46
-4%
25
-46%
22
-13%
26
+20%
31
+17%
29
-5%
30
+3%
25
-17%
20
-22%
29
+48%
22
-25%
21
-5%
23
+9%
12
-49%
12
+3%
49
+312%
48
-2%
49
+3%
54
+9%
18
-67%
32
+80%
79
+147%
114
+44%
157
+38%
188
+20%
204
+8%
238
+17%
271
+14%
290
+7%
307
+6%
318
+4%
331
+4%
355
+7%
382
+8%
413
+8%
Gross Profit
Cost of Revenue
(0)
(0)
(0)
(1)
(2)
(2)
(2)
(1)
(0)
(3)
(3)
(3)
(4)
(2)
(2)
(2)
(1)
(1)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(8)
(8)
(7)
(7)
(2)
(2)
(5)
(7)
(7)
(8)
(6)
(5)
(5)
(6)
(8)
Gross Profit
19
N/A
14
-28%
17
+25%
41
+142%
47
+16%
46
-2%
44
-4%
24
-47%
22
-9%
24
+9%
28
+18%
26
-6%
26
0%
24
-10%
18
-23%
27
+50%
21
-22%
20
-5%
21
+3%
10
-52%
10
+3%
45
+337%
45
+1%
47
+3%
49
+6%
16
-67%
25
+53%
71
+190%
107
+50%
150
+40%
186
+24%
202
+8%
234
+16%
264
+13%
282
+7%
299
+6%
312
+4%
327
+5%
350
+7%
376
+7%
405
+8%
Operating Income
Operating Expenses
(56)
(59)
(70)
(77)
(85)
(86)
(88)
(85)
(79)
(72)
(68)
(70)
(74)
(81)
(82)
(88)
(93)
(99)
(122)
(128)
(135)
(144)
(156)
(161)
(172)
(191)
(212)
(250)
(287)
(328)
(307)
(328)
(332)
(413)
(409)
(412)
(419)
(429)
(469)
(437)
(445)
Selling, General & Administrative
(7)
(8)
(10)
(11)
(12)
(13)
(12)
(11)
(11)
(11)
(11)
(11)
(12)
(14)
(14)
(14)
(14)
(14)
(17)
(23)
(31)
(37)
(47)
(52)
(57)
(68)
(74)
(87)
(104)
(119)
(131)
(143)
(145)
(159)
(173)
(186)
(200)
(214)
(225)
(236)
(250)
Research & Development
(48)
(52)
(60)
(65)
(72)
(73)
(76)
(74)
(68)
(61)
(57)
(59)
(62)
(67)
(69)
(74)
(78)
(85)
(94)
(101)
(104)
(107)
(109)
(109)
(114)
(123)
(136)
(161)
(181)
(209)
(232)
(241)
(244)
(253)
(236)
(226)
(220)
(215)
(215)
(201)
(195)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(11)
(5)
0
0
0
0
0
0
(2)
0
(2)
0
56
56
56
0
0
0
0
0
(29)
0
0
Operating Income
(37)
N/A
(46)
-24%
(53)
-15%
(36)
+32%
(37)
-4%
(39)
-5%
(44)
-12%
(62)
-40%
(58)
+6%
(49)
+16%
(40)
+17%
(44)
-8%
(48)
-9%
(57)
-20%
(64)
-12%
(60)
+6%
(71)
-18%
(78)
-10%
(101)
-29%
(118)
-16%
(125)
-6%
(100)
+20%
(111)
-12%
(115)
-3%
(122)
-7%
(175)
-43%
(187)
-7%
(178)
+5%
(180)
-1%
(178)
+1%
(120)
+32%
(126)
-4%
(98)
+22%
(148)
-51%
(127)
+14%
(113)
+11%
(107)
+5%
(102)
+5%
(119)
-16%
(60)
+49%
(41)
+33%
Pre-Tax Income
Interest Income Expense
(2)
1
3
5
1
(4)
(7)
(10)
(11)
(7)
(6)
(4)
(3)
(8)
(8)
(7)
(7)
(7)
(5)
(8)
(9)
(9)
(4)
(2)
(2)
(6)
(22)
(36)
(47)
(60)
(71)
(81)
(90)
(96)
(96)
(98)
(98)
(94)
(90)
(86)
(83)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
(11)
(16)
(16)
0
0
0
0
0
0
0
(2)
0
0
0
56
0
0
0
0
0
(29)
(29)
(31)
0
0
0
Pre-Tax Income
(39)
N/A
(45)
-16%
(50)
-11%
(31)
+39%
(37)
-19%
(43)
-18%
(51)
-18%
(72)
-42%
(69)
+4%
(55)
+20%
(47)
+16%
(47)
-1%
(51)
-8%
(66)
-30%
(77)
-18%
(79)
-2%
(93)
-18%
(101)
-8%
(107)
-5%
(126)
-18%
(134)
-6%
(109)
+19%
(115)
-6%
(116)
-1%
(125)
-7%
(183)
-46%
(210)
-15%
(214)
-2%
(227)
-6%
(182)
+20%
(191)
-5%
(206)
-8%
(188)
+9%
(244)
-30%
(223)
+9%
(240)
-7%
(235)
+2%
(226)
+4%
(209)
+8%
(146)
+30%
(124)
+15%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
(3)
(3)
(5)
(3)
(3)
(3)
(2)
(0)
(0)
1
0
Income from Continuing Operations
(39)
(45)
(50)
(31)
(37)
(43)
(51)
(72)
(69)
(55)
(47)
(47)
(51)
(66)
(77)
(79)
(93)
(101)
(107)
(126)
(134)
(109)
(115)
(116)
(125)
(183)
(210)
(214)
(227)
(184)
(194)
(210)
(193)
(247)
(226)
(243)
(236)
(227)
(209)
(146)
(124)
Net Income (Common)
(39)
N/A
(45)
-16%
(50)
-11%
(31)
+39%
(37)
-19%
(43)
-18%
(51)
-18%
(72)
-42%
(69)
+4%
(55)
+20%
(47)
+16%
(47)
-1%
(51)
-8%
(66)
-30%
(77)
-18%
(79)
-2%
(93)
-18%
(101)
-8%
(107)
-5%
(126)
-18%
(134)
-6%
(109)
+19%
(115)
-6%
(116)
-1%
(125)
-7%
(183)
-46%
(210)
-15%
(214)
-2%
(227)
-6%
(184)
+19%
(194)
-5%
(210)
-8%
(193)
+8%
(247)
-28%
(226)
+8%
(243)
-7%
(236)
+3%
(227)
+4%
(209)
+8%
(146)
+30%
(124)
+15%
EPS (Diluted)
-0.54
N/A
-0.68
-26%
-0.69
-1%
-0.39
+43%
-0.51
-31%
-0.59
-16%
-0.7
-19%
-0.98
-40%
-0.94
+4%
-0.75
+20%
-0.63
+16%
-0.58
+8%
-0.6
-3%
-0.78
-30%
-0.78
N/A
-0.79
-1%
-0.88
-11%
-0.98
-11%
-0.96
+2%
-1.15
-20%
-1.21
-5%
-0.94
+22%
-0.74
+21%
-0.72
+3%
-0.7
+3%
-1.09
-56%
-1.2
-10%
-1.2
N/A
-1.27
-6%
-1.03
+19%
-1.04
-1%
-1.12
-8%
-1.05
+6%
-1.33
-27%
-1.21
+9%
-1.29
-7%
-1.25
+3%
-1.18
+6%
-1.01
+14%
-0.7
+31%
-0.61
+13%

See Also

Discover More